What are Vasodilator drugs?

Vasodilator drugs are pharmacologic agents that share a common mechanism (typically targeting Atrial natriuretic peptide receptor 1). 2 are currently marketed, with 4 more in clinical development.

What are the marketed Vasodilator drugs?

Marketed Vasodilator drugs include Standard Oral Vasodilators, Sodium Nitroprusside.

Vasodilator

2 marketed 3 in Phase 3 1 in Phase 2

This page covers all Vasodilator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Atrial natriuretic peptide receptor 1, guanylate cyclase, prostaglandin E1 receptor.

Targets

Atrial natriuretic peptide receptor 1 · guanylate cyclase · prostaglandin E1 receptor

Marketed (2)

Standard Oral Vasodilators · The Cleveland Clinic · Cardiovascular
Oral vasodilators relax blood vessel smooth muscle to widen blood vessels and reduce blood pressure.
Sodium Nitroprusside · Roche · Cardiovascular

Phase 3 pipeline (3)

dl-3-n-butylphthalide (NBP) · yuanli Zhao · Cerebrovascular Disease
DL-3-n-butylphthalide (NBP) is a small molecule that acts as a vasodilator and neuroprotective agent.
glyceryl nitrate · Hvidovre University Hospital · Cardiovascular
Glyceryl nitrate acts as a vasodilator by releasing nitric oxide, which relaxes vascular smooth muscle and reduces blood pressure.
sublingual nitroglycerine · United States Naval Medical Center, San Diego · Cardiovascular
Sublingual nitroglycerine works by releasing nitric oxide, which relaxes vascular smooth muscle and reduces blood pressure.

Phase 2 pipeline (1)

Alprostadil Liposomes for Injection · Guangzhou Yipinhong Pharmaceutical CO.,LTD · Cardiovascular
vasodilation via prostaglandin E1 receptor agonism